Highlights and Quick Summary
- Annual ROE for 2022 was -2.89% (a -91.57% decrease from previous year)
- Annual ROE for 2021 was -34.29% (a -20.53% decrease from previous year)
- Annual ROE for 2020 was -43.15% (a 1072.55% increase from previous year)
- Twelve month ROE ending February 28, 2023 was -2.2% (a 34.97% increase compared to previous quarter)
- Twelve month trailing ROE decreased by -68.57% year-over-year
Trailing ROE for the last four month:
| 28 Feb '23 | 30 Nov '22 | 31 Aug '22 | 31 May '22 |
|---|---|---|---|
| -2.2% | -1.63% | -2.89% | -7.0% |
Visit stockrow.com/OGI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical ROE of Organigram Holdings Inc.
Most recent ROEof OGI including historical data for past 10 years.Interactive Chart of ROE of Organigram Holdings Inc.
Organigram Holdings Inc. ROE for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | – | – | – | -2.89% |
| 2021 | – | – | – | – | -34.29% |
| 2020 | – | – | – | – | -43.15% |
| 2019 | – | – | – | – | -3.68% |
| 2018 | – | – | – | – | 15.3% |
| 2017 | – | – | – | – | -17.29% |
| 2016 | – | – | – | – | 1.3% |
Business Profile of Organigram Holdings Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic